Logo image of CFX.CA

CANFOR PULP PRODUCTS INC (CFX.CA) Stock Fundamental Analysis

Canada - TSX:CFX - CA1375842079 - Common Stock

0.405 CAD
0 (0%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CFX scores 3 out of 10 in our fundamental rating. CFX was compared to 12 industry peers in the Paper & Forest Products industry. CFX may be in some trouble as it scores bad on both profitability and health. CFX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CFX was profitable.
CFX had a positive operating cash flow in the past year.
In the past 5 years CFX always reported negative net income.
In the past 5 years CFX always reported a positive cash flow from operatings.
CFX.CA Yearly Net Income VS EBIT VS OCF VS FCFCFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of -35.35%, CFX is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
CFX has a Return On Equity of -87.05%. This is amonst the worse of the industry: CFX underperforms 91.67% of its industry peers.
CFX's Return On Invested Capital of 2.73% is amongst the best of the industry. CFX outperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -35.35%
ROE -87.05%
ROIC 2.73%
ROA(3y)-20.14%
ROA(5y)-13.63%
ROE(3y)-46.33%
ROE(5y)-30.44%
ROIC(3y)N/A
ROIC(5y)N/A
CFX.CA Yearly ROA, ROE, ROICCFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

With a Operating Margin value of 1.55%, CFX perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
CFX's Gross Margin of 22.02% is fine compared to the rest of the industry. CFX outperforms 75.00% of its industry peers.
CFX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.55%
PM (TTM) N/A
GM 22.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.78%
GM growth 5Y-0.73%
CFX.CA Yearly Profit, Operating, Gross MarginsCFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CFX is destroying value.
The number of shares outstanding for CFX remains at a similar level compared to 1 year ago.
The number of shares outstanding for CFX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CFX has a worse debt to assets ratio.
CFX.CA Yearly Shares OutstandingCFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CFX.CA Yearly Total Debt VS Total AssetsCFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CFX has an Altman-Z score of 0.83. This is a bad value and indicates that CFX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.83, CFX is doing worse than 83.33% of the companies in the same industry.
CFX has a debt to FCF ratio of 5.18. This is a neutral value as CFX would need 5.18 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.18, CFX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CFX has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.43, CFX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.18
Altman-Z 0.83
ROIC/WACC0.28
WACC9.69%
CFX.CA Yearly LT Debt VS Equity VS FCFCFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

CFX has a Current Ratio of 0.98. This is a bad value and indicates that CFX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.98, CFX is doing worse than 83.33% of the companies in the same industry.
CFX has a Quick Ratio of 0.98. This is a bad value and indicates that CFX is not financially healthy enough and could expect problems in meeting its short term obligations.
CFX has a Quick ratio of 0.23. This is amonst the worse of the industry: CFX underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.23
CFX.CA Yearly Current Assets VS Current LiabilitesCFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

CFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.37%, which is quite impressive.
Looking at the last year, CFX shows a very negative growth in Revenue. The Revenue has decreased by -11.47% in the last year.
Measured over the past years, CFX shows a decrease in Revenue. The Revenue has been decreasing by -6.00% on average per year.
EPS 1Y (TTM)103.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)-11.47%
Revenue growth 3Y-11.31%
Revenue growth 5Y-6%
Sales Q2Q%-19.14%

3.2 Future

Based on estimates for the next years, CFX will show a very strong growth in Earnings Per Share. The EPS will grow by 47.59% on average per year.
CFX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.88% yearly.
EPS Next Y-140.85%
EPS Next 2Y-43.03%
EPS Next 3Y29.17%
EPS Next 5Y47.59%
Revenue Next Year-15.23%
Revenue Next 2Y-8.73%
Revenue Next 3Y-4.88%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CFX.CA Yearly Revenue VS EstimatesCFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CFX.CA Yearly EPS VS EstimatesCFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.50, CFX is valued correctly.
Based on the Price/Earnings ratio, CFX is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.49, CFX is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for CFX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 13.5
Fwd PE N/A
CFX.CA Price Earnings VS Forward Price EarningsCFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than CFX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CFX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.79
EV/EBITDA 0.48
CFX.CA Per share dataCFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as CFX's earnings are expected to grow with 29.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.03%
EPS Next 3Y29.17%

0

5. Dividend

5.1 Amount

CFX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANFOR PULP PRODUCTS INC

TSX:CFX (10/14/2025, 7:00:00 PM)

0.405

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-05 2025-11-05
Inst Owners19.88%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap26.42M
Analysts72.5
Price Target0.84 (107.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-51.38%
Min EPS beat(2)-89%
Max EPS beat(2)-13.76%
EPS beat(4)2
Avg EPS beat(4)25.64%
Min EPS beat(4)-89%
Max EPS beat(4)138.33%
EPS beat(8)5
Avg EPS beat(8)29.75%
EPS beat(12)6
Avg EPS beat(12)-72.2%
EPS beat(16)7
Avg EPS beat(16)-84.6%
Revenue beat(2)1
Avg Revenue beat(2)1.94%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)4.48%
Revenue beat(4)2
Avg Revenue beat(4)-2.72%
Min Revenue beat(4)-15.23%
Max Revenue beat(4)4.48%
Revenue beat(8)4
Avg Revenue beat(8)-1.67%
Revenue beat(12)6
Avg Revenue beat(12)-0.66%
Revenue beat(16)9
Avg Revenue beat(16)0.24%
PT rev (1m)-18.32%
PT rev (3m)-31.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-94.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-214.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE 13.5
Fwd PE N/A
P/S 0.04
P/FCF 1.79
P/OCF 0.5
P/B 0.15
P/tB 0.15
EV/EBITDA 0.48
EPS(TTM)0.03
EY7.41%
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)0.23
FCFY56.02%
OCF(TTM)0.82
OCFY201.76%
SpS11.2
BVpS2.71
TBVpS2.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.35%
ROE -87.05%
ROCE 5.07%
ROIC 2.73%
ROICexc 2.74%
ROICexgc 2.74%
OM 1.55%
PM (TTM) N/A
GM 22.02%
FCFM 2.03%
ROA(3y)-20.14%
ROA(5y)-13.63%
ROE(3y)-46.33%
ROE(5y)-30.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.78%
GM growth 5Y-0.73%
F-Score5
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.18
Debt/EBITDA 1.36
Cap/Depr 86.32%
Cap/Sales 5.27%
Interest Coverage 1.06
Cash Conversion 95.35%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.23
Altman-Z 0.83
F-Score5
WACC9.69%
ROIC/WACC0.28
Cap/Depr(3y)90.9%
Cap/Depr(5y)90.41%
Cap/Sales(3y)7.88%
Cap/Sales(5y)7.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y-140.85%
EPS Next 2Y-43.03%
EPS Next 3Y29.17%
EPS Next 5Y47.59%
Revenue 1Y (TTM)-11.47%
Revenue growth 3Y-11.31%
Revenue growth 5Y-6%
Sales Q2Q%-19.14%
Revenue Next Year-15.23%
Revenue Next 2Y-8.73%
Revenue Next 3Y-4.88%
Revenue Next 5YN/A
EBIT growth 1Y114.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year122.25%
EBIT Next 3Y32.72%
EBIT Next 5Y25.98%
FCF growth 1Y260.98%
FCF growth 3Y-52.34%
FCF growth 5YN/A
OCF growth 1Y-35.71%
OCF growth 3Y-26.8%
OCF growth 5Y-0.34%